Founded Year



Angel | Alive

Total Raised


Last Raised

$500K | 1 yr ago

About SentiAR

SentiAR is a software device company that develops a 3D visualization platform with real-time cardiac holograms for real-time intraprocedural use, resulting in a safer, faster procedure.

SentiAR Headquarter Location

212 N Kingshighway Blvd Suite #115

St. Louis, Missouri, 63108,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing SentiAR

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SentiAR is included in 5 Expert Collections, including AR/VR.



1,370 items


Medical Devices

11,483 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

7,900 items

SentiAR Patents

SentiAR has filed 9 patents.

The 3 most popular patent topics include:

  • Augmented reality
  • Mixed reality
  • Sensors
patents chart

Application Date

Grant Date


Related Topics




Sensors, Wireless networking, Broadcast engineering, Telecommunications equipment, Videotelephony


Application Date


Grant Date



Related Topics

Sensors, Wireless networking, Broadcast engineering, Telecommunications equipment, Videotelephony



Latest SentiAR News

Magic Leap Goes After Medical Customers With Augmented Reality Headset

Jan 12, 2022

6:45 PM IST, 12 Jan 2022 6:30 PM IST, 12 Jan 2022 6:45 PM IST, 12 Jan 2022 Save (Bloomberg) -- Magic Leap Inc., the augmented reality company that struggled to turn its headset into a consumer hit, is now going after surgeons and other medical customers as part of a pivot toward health care, defense and manufacturing markets. (Bloomberg) -- Magic Leap Inc., the augmented reality company that struggled to turn its headset into a consumer hit, is now going after surgeons and other medical customers as part of a pivot toward health care, defense and manufacturing markets. Its latest product, an AR headset due midyear called Magic Leap 2, is already being used by companies such as heart-mapping startup SentiAR Inc. and the neurotechnology business SyncThink Inc. Other companies getting early access to the technology include Heru Inc., which plans personalized vision-correction applications, and Brainlab AG, the maker of a mixed reality program for reviewing surgical plans and collaborating with colleagues. Magic Leap had initially raised $3.5 billion from high-profile investors such as Alphabet Inc. with the hopes of turning AR into a viable consumer technology. But it scrapped those ambitions and refocused on business customers, hiring Microsoft Corp. veteran Peggy Johnson in 2020 to lead the effort. She raised a further $500 million and narrowed the company’s scope to the handful of markets that may be most receptive to AR — a cousin to virtual reality that melds computer imagery with real life views. It’s easiest to make inroads with “industries that are used to wearing something on their eyes,” she said in an interview. “If it’s a surgeon, maybe it’s a magnifier or lights. Manufacturing, they’re wearing safety things. So we see acceptance of something on your eyes already.” The new device has improvements that are key for health care. A larger field of view expands vertically, so a surgeon or doctor can look up at virtual screens and then back down at any holographic images on the patient, Johnson said. There’s also a dimming feature that fades out bright backgrounds, like a well-lit operating room, to zoom in on the part of a patient’s anatomy that surgeons are operating on, she said. And the device is smaller and lighter, making it easier to wear. Because of the new features, Magic Leap 2 will be “slightly” pricier than the current version, which ranges from $2,295 to $2,995, she said. Magic Leap, founded in 2010, came early to an augmented reality market that has been slow to go mainstream. Microsoft joined the fray in later years with HoloLens, and Facebook owner Meta Platforms Inc. and Apple Inc. are developing AR products. But neither Magic Leap nor Microsoft has disclosed sales figures for their devices. For now, virtual reality — a more immersive experience — is a far bigger market. Research firm IDC estimates  that nearly 90% of headset sales comes from VR rather than AR. Magic Leap is also going after military and manufacturing customers, but Johnson declined to name clients in those areas. The military applications largely revolve around training, while manufacturing companies want to use the device for things like education, repairs and remote access to experts, she said. Johnson’s own company used its goggles to set up its manufacturing plants in Mexico for the new hardware when the pandemic halted travel. Working with the military can be controversial. Microsoft, which has a contract with the U.S. Army to provide a customized version of its goggles, faced employee protests over the $22 billion deal. Johnson said that using AR for training purposes is appropriate. “Our interaction has been positive with the Department of Defense,” she said. “Right now, we’re trying to stay focused, and it is all about training. And I think giving our soldiers the best training possible is a good mission for us to undertake.” Magic Leap hasn’t given up on the consumer market in the long run, she said. Johnson is “absolutely” interested in going after those customers again someday, but she wants to wait for more compelling applications. The technology also needs to get cheaper and small enough to fit into more ordinary glasses, she said. ©2022 Bloomberg L.P.

SentiAR Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

SentiAR Rank

  • When was SentiAR founded?

    SentiAR was founded in 2017.

  • Where is SentiAR's headquarters?

    SentiAR's headquarters is located at 212 N Kingshighway Blvd, St. Louis.

  • What is SentiAR's latest funding round?

    SentiAR's latest funding round is Angel.

  • How much did SentiAR raise?

    SentiAR raised a total of $15.73M.

  • Who are the investors of SentiAR?

    Investors of SentiAR include St. Louis Arch Angels, Cultivation Capital, BioGenerator, National Institutes of Health, Arch Grants and 3 more.

  • Who are SentiAR's competitors?

    Competitors of SentiAR include Osso VR.

You May Also Like

Precision OS Technology

Precision OS provides orthopedic surgical education in virtual reality (VR). Its software allows practicing surgeons to perform simulated medical procedures in a realistic digital operating room and offers metric feedback to help users improve their techniques. Custom virtual educational modules provide a medium for surgeons and trainees to make decisions, evaluate outcomes and repeat, improving surgical skills through repetition. The Precision preoperative tool enables surgeons to upload complex, peri-articular fractures to structure a pre-planned approach to their case.

ORamaVR Logo

ORamaVR offers a platform that empowers institutions and developers to create high-fidelity medical VR simulations. It was founded in 2016 and is based in Plan-les-Ouates, Switzerland.

Proprio Logo

Proprio is a computational imaging company that provides enhanced visualization systems for precision tasks such as brain surgery.

TrueVision Systems

TrueVision Systems, dba TrueVisions 3D Surgical, provides digital 3D visualization and guidance for microsurgery. The company has developed an intelligent, real-time, 3D surgical visualization and computer-aided guidance platform. TrueVision combines 3D visualization and guidance software applications focused on improving accuracy, efficiency, and outcomes for both surgeons and patients. The company is developing 3D guidance applications for microsurgery to improve surgical efficiencies and patient outcomes. The Refractive Cataract Toolset is a computer-aided software for astigmatic correction and advanced IOL positioning.

FundamentalVR Logo

FundamentlaVR provides training, simulation, and education services using virtual and mixed reality. Its Haptic Intelligence Engine delivers high-fidelity physical interaction to its users. It serves clients operating in the medical and communications market. It was founded in 2012 and is based in London, England.

ImmersiveTouch Logo

ImmersiveTouch is a provider in simulation-based surgical training and exploration. ImmersiveTouch simulators 'immerse' surgeons in a 3D operating environment with high-fidelity virtual anatomies and haptic instrument replicates. Most surgeons who have interacted with our simulator say that it is like doing real surgery. The company develops, installs, and manages simulators for surgery training and pre-operative surgical planning at Academic Medical Centers, Teaching Hospitals and Surgery Centers.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.